APO Research
Talk to an analyst

APO RESEARCH · REPORT

D(-)-Alpha-Phenylglycine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global D(-)-Alpha-Phenylglycine Market Outlook and Growth Opportunities 2026

23 December 2025199 pages

Choose your research edition.

Industry ResearchD(-)-Alpha-Phenylglycine Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal D(-)-Alpha-Phenylglycine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal D(-)-Alpha-Phenylglycine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal D(-)-Alpha-Phenylglycine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal D(-)-Alpha-Phenylglycine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global D(-)-Alpha-Phenylglycine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for D(-)-Alpha-Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for D(-)-Alpha-Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for D(-)-Alpha-Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the D(-)-Alpha-Phenylglycine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the D(-)-Alpha-Phenylglycine market include Zhejiang Yuntao Biotechnology, JIN Yimeng Group and Hebei Zeshuo Pharmaceutical Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global D(-)-Alpha-Phenylglycine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of D(-)-Alpha-Phenylglycine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents D(-)-Alpha-Phenylglycine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the D(-)-Alpha-Phenylglycine market size, projected growth trends, production technologies, key applications, and end-use industries.

D(-)-Alpha-Phenylglycine Segment by Company

Zhejiang Yuntao Biotechnology

JIN Yimeng Group

Hebei Zeshuo Pharmaceutical Technology

D(-)-Alpha-Phenylglycine Segment by Type

Purity ≥98.5%

Purity <98.5%

D(-)-Alpha-Phenylglycine Segment by Application

Penicillin Intermediates

Cephalexin Intermediates

D(-)-Alpha-Phenylglycine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global D(-)-Alpha-Phenylglycine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions D(-)-Alpha-Phenylglycine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify D(-)-Alpha-Phenylglycine significant trends, drivers, influence factors in global and regions.

6. To analyze D(-)-Alpha-Phenylglycine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global D(-)-Alpha-Phenylglycine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of D(-)-Alpha-Phenylglycine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of D(-)-Alpha-Phenylglycine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the D(-)-Alpha-Phenylglycine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global D(-)-Alpha-Phenylglycine industry.

Chapter 3: Detailed analysis of D(-)-Alpha-Phenylglycine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of D(-)-Alpha-Phenylglycine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of D(-)-Alpha-Phenylglycine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. D(-)-Alpha-Phenylglycine Industry Trends Table 2. D(-)-Alpha-Phenylglycine Industry Drivers Table 3. D(-)-Alpha-Phenylglycine Industry Opportunities and Challenges Table 4. D(-)-Alpha-Phenylglycine Industry Restraints Table 5. Global D(-)-Alpha-Phenylglycine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global D(-)-Alpha-Phenylglycine Revenue Share by Company (2021-2026) Table 7. Global D(-)-Alpha-Phenylglycine Sales Volume by Company (t) & (2021-2026) Table 8. Global D(-)-Alpha-Phenylglycine Sales Volume Share by Company (2021-2026) Table 9. Global D(-)-Alpha-Phenylglycine Average Price (USD/t) of Company (2021-2026) Table 10. Global D(-)-Alpha-Phenylglycine Company Ranking, (2024-2026) & (USD Million) Table 11. Global D(-)-Alpha-Phenylglycine Key Company Manufacturing Base & Headquarters Table 12. Global D(-)-Alpha-Phenylglycine Company, Product Type & Application Table 13. Global D(-)-Alpha-Phenylglycine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global D(-)-Alpha-Phenylglycine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≥98.5% Table 18. Significant Companies of Purity <98.5% Table 19. Global D(-)-Alpha-Phenylglycine Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global D(-)-Alpha-Phenylglycine Sales Volume by Type (2021-2026) & (t) Table 21. Global D(-)-Alpha-Phenylglycine Sales Volume by Type (2027-2032) & (t) Table 22. Global D(-)-Alpha-Phenylglycine Sales Volume Share by Type (2021-2026) Table 23. Global D(-)-Alpha-Phenylglycine Sales Volume Share by Type (2027-2032) Table 24. Global D(-)-Alpha-Phenylglycine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global D(-)-Alpha-Phenylglycine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global D(-)-Alpha-Phenylglycine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global D(-)-Alpha-Phenylglycine Sales Value Share by Type (2021-2026) Table 28. Global D(-)-Alpha-Phenylglycine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Penicillin Intermediates Table 30. Significant Companies of Cephalexin Intermediates Table 31. Global D(-)-Alpha-Phenylglycine Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 32. Global D(-)-Alpha-Phenylglycine Sales Volume by Application (2021-2026) & (t) Table 33. Global D(-)-Alpha-Phenylglycine Sales Volume by Application (2027-2032) & (t) Table 34. Global D(-)-Alpha-Phenylglycine Sales Volume Share by Application (2021-2026) Table 35. Global D(-)-Alpha-Phenylglycine Sales Volume Share by Application (2027-2032) Table 36. Global D(-)-Alpha-Phenylglycine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global D(-)-Alpha-Phenylglycine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global D(-)-Alpha-Phenylglycine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global D(-)-Alpha-Phenylglycine Sales Value Share by Application (2021-2026) Table 40. Global D(-)-Alpha-Phenylglycine Sales Value Share by Application (2027-2032) Table 41. Global D(-)-Alpha-Phenylglycine Sales by Region: 2021 VS 2025 VS 2032 (t) Table 42. Global D(-)-Alpha-Phenylglycine Sales by Region (2021-2026) & (t) Table 43. Global D(-)-Alpha-Phenylglycine Sales Market Share by Region (2021-2026) Table 44. Global D(-)-Alpha-Phenylglycine Sales by Region (2027-2032) & (t) Table 45. Global D(-)-Alpha-Phenylglycine Sales Market Share by Region (2027-2032) Table 46. Global D(-)-Alpha-Phenylglycine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global D(-)-Alpha-Phenylglycine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global D(-)-Alpha-Phenylglycine Sales Value Share by Region (2021-2026) Table 49. Global D(-)-Alpha-Phenylglycine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global D(-)-Alpha-Phenylglycine Sales Value Share by Region (2027-2032) Table 51. Global D(-)-Alpha-Phenylglycine Market Average Price (USD/t) by Region (2021-2026) Table 52. Global D(-)-Alpha-Phenylglycine Market Average Price (USD/t) by Region (2027-2032) Table 53. Global D(-)-Alpha-Phenylglycine Sales by Country: 2021 VS 2025 VS 2032 (t) Table 54. Global D(-)-Alpha-Phenylglycine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global D(-)-Alpha-Phenylglycine Sales by Country (2021-2026) & (t) Table 56. Global D(-)-Alpha-Phenylglycine Sales Market Share by Country (2021-2026) Table 57. Global D(-)-Alpha-Phenylglycine Sales by Country (2027-2032) & (t) Table 58. Global D(-)-Alpha-Phenylglycine Sales Market Share by Country (2027-2032) Table 59. Global D(-)-Alpha-Phenylglycine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global D(-)-Alpha-Phenylglycine Sales Value Market Share by Country (2021-2026) Table 61. Global D(-)-Alpha-Phenylglycine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global D(-)-Alpha-Phenylglycine Sales Value Market Share by Country (2027-2032) Table 63. Zhejiang Yuntao Biotechnology Company Information Table 64. Zhejiang Yuntao Biotechnology Business Overview Table 65. Zhejiang Yuntao Biotechnology D(-)-Alpha-Phenylglycine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 66. Zhejiang Yuntao Biotechnology D(-)-Alpha-Phenylglycine Product Portfolio Table 67. Zhejiang Yuntao Biotechnology Recent Development Table 68. JIN Yimeng Group Company Information Table 69. JIN Yimeng Group Business Overview Table 70. JIN Yimeng Group D(-)-Alpha-Phenylglycine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 71. JIN Yimeng Group D(-)-Alpha-Phenylglycine Product Portfolio Table 72. JIN Yimeng Group Recent Development Table 73. Hebei Zeshuo Pharmaceutical Technology Company Information Table 74. Hebei Zeshuo Pharmaceutical Technology Business Overview Table 75. Hebei Zeshuo Pharmaceutical Technology D(-)-Alpha-Phenylglycine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. Hebei Zeshuo Pharmaceutical Technology D(-)-Alpha-Phenylglycine Product Portfolio Table 77. Hebei Zeshuo Pharmaceutical Technology Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. D(-)-Alpha-Phenylglycine Distributors List Table 81. D(-)-Alpha-Phenylglycine Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. D(-)-Alpha-Phenylglycine Product Image Figure 2. Global D(-)-Alpha-Phenylglycine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global D(-)-Alpha-Phenylglycine Sales Value (2021-2032) & (US$ Million) Figure 4. Global D(-)-Alpha-Phenylglycine Sales (2021-2032) & (t) Figure 5. Global D(-)-Alpha-Phenylglycine Sales Average Price (USD/t) & (2021-2032) Figure 6. Global D(-)-Alpha-Phenylglycine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥98.5% Image Figure 10. Purity <98.5% Image Figure 11. Global D(-)-Alpha-Phenylglycine Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global D(-)-Alpha-Phenylglycine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global D(-)-Alpha-Phenylglycine Sales Volume Share by Type (2021-2032) Figure 14. Global D(-)-Alpha-Phenylglycine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global D(-)-Alpha-Phenylglycine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global D(-)-Alpha-Phenylglycine Sales Value Share by Type (2021-2032) Figure 17. Penicillin Intermediates Image Figure 18. Cephalexin Intermediates Image Figure 19. Global D(-)-Alpha-Phenylglycine Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 20. Global D(-)-Alpha-Phenylglycine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global D(-)-Alpha-Phenylglycine Sales Volume Share by Application (2021-2032) Figure 22. Global D(-)-Alpha-Phenylglycine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global D(-)-Alpha-Phenylglycine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global D(-)-Alpha-Phenylglycine Sales Value Share by Application (2021-2032) Figure 25. Global D(-)-Alpha-Phenylglycine Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 26. Global D(-)-Alpha-Phenylglycine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global D(-)-Alpha-Phenylglycine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global D(-)-Alpha-Phenylglycine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America D(-)-Alpha-Phenylglycine Sales Value (2021-2032) & (US$ Million) Figure 30. North America D(-)-Alpha-Phenylglycine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe D(-)-Alpha-Phenylglycine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe D(-)-Alpha-Phenylglycine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific D(-)-Alpha-Phenylglycine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific D(-)-Alpha-Phenylglycine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America D(-)-Alpha-Phenylglycine Sales Value (2021-2032) & (US$ Million) Figure 36. South America D(-)-Alpha-Phenylglycine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa D(-)-Alpha-Phenylglycine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa D(-)-Alpha-Phenylglycine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. D(-)-Alpha-Phenylglycine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. D(-)-Alpha-Phenylglycine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥98.5%
  • Purity <98.5%
Applications
  • Penicillin Intermediates
  • Cephalexin Intermediates
Companies covered
  • Zhejiang Yuntao Biotechnology
  • JIN Yimeng Group
  • Hebei Zeshuo Pharmaceutical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global D(-)-Alpha-Phenylglycine Sales Value (2021-2032)
  4. 1.2.2 Global D(-)-Alpha-Phenylglycine Sales Volume (2021-2032)
  5. 1.2.3 Global D(-)-Alpha-Phenylglycine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 D(-)-Alpha-Phenylglycine Market Dynamics
  1. 2.1 D(-)-Alpha-Phenylglycine Industry Trends
  2. 2.2 D(-)-Alpha-Phenylglycine Industry Drivers
  3. 2.3 D(-)-Alpha-Phenylglycine Industry Opportunities and Challenges
  4. 2.4 D(-)-Alpha-Phenylglycine Industry Restraints
3 D(-)-Alpha-Phenylglycine Market by Company
  1. 3.1 Global D(-)-Alpha-Phenylglycine Company Revenue Ranking in 2025
  2. 3.2 Global D(-)-Alpha-Phenylglycine Revenue by Company (2021-2026)
  3. 3.3 Global D(-)-Alpha-Phenylglycine Sales Volume by Company (2021-2026)
  4. 3.4 Global D(-)-Alpha-Phenylglycine Average Price by Company (2021-2026)
  5. 3.5 Global D(-)-Alpha-Phenylglycine Company Ranking (2024-2026)
  6. 3.6 Global D(-)-Alpha-Phenylglycine Company Manufacturing Base and Headquarters
  7. 3.7 Global D(-)-Alpha-Phenylglycine Company Product Type and Application
  8. 3.8 Global D(-)-Alpha-Phenylglycine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global D(-)-Alpha-Phenylglycine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 D(-)-Alpha-Phenylglycine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 D(-)-Alpha-Phenylglycine Market by Type
  1. 4.1 D(-)-Alpha-Phenylglycine Type Introduction
  2. 4.1.1 Purity ≥98.5%
  3. 4.1.2 Purity <98.5%
  4. 4.2 Global D(-)-Alpha-Phenylglycine Sales Volume by Type
  5. 4.2.1 Global D(-)-Alpha-Phenylglycine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global D(-)-Alpha-Phenylglycine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global D(-)-Alpha-Phenylglycine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global D(-)-Alpha-Phenylglycine Sales Value by Type
  9. 4.3.1 Global D(-)-Alpha-Phenylglycine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global D(-)-Alpha-Phenylglycine Sales Value by Type (2021-2032)
  11. 4.3.3 Global D(-)-Alpha-Phenylglycine Sales Value Share by Type (2021-2032)
5 D(-)-Alpha-Phenylglycine Market by Application
  1. 5.1 D(-)-Alpha-Phenylglycine Application Introduction
  2. 5.1.1 Penicillin Intermediates
  3. 5.1.2 Cephalexin Intermediates
  4. 5.2 Global D(-)-Alpha-Phenylglycine Sales Volume by Application
  5. 5.2.1 Global D(-)-Alpha-Phenylglycine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global D(-)-Alpha-Phenylglycine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global D(-)-Alpha-Phenylglycine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global D(-)-Alpha-Phenylglycine Sales Value by Application
  9. 5.3.1 Global D(-)-Alpha-Phenylglycine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global D(-)-Alpha-Phenylglycine Sales Value by Application (2021-2032)
  11. 5.3.3 Global D(-)-Alpha-Phenylglycine Sales Value Share by Application (2021-2032)
6 D(-)-Alpha-Phenylglycine Regional Sales and Value Analysis
  1. 6.1 Global D(-)-Alpha-Phenylglycine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global D(-)-Alpha-Phenylglycine Sales by Region (2021-2032)
  3. 6.2.1 Global D(-)-Alpha-Phenylglycine Sales by Region: 2021-2026
  4. 6.2.2 Global D(-)-Alpha-Phenylglycine Sales by Region (2027-2032)
  5. 6.3 Global D(-)-Alpha-Phenylglycine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global D(-)-Alpha-Phenylglycine Sales Value by Region (2021-2032)
  7. 6.4.1 Global D(-)-Alpha-Phenylglycine Sales Value by Region: 2021-2026
  8. 6.4.2 Global D(-)-Alpha-Phenylglycine Sales Value by Region (2027-2032)
  9. 6.5 Global D(-)-Alpha-Phenylglycine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America D(-)-Alpha-Phenylglycine Sales Value (2021-2032)
  12. 6.6.2 North America D(-)-Alpha-Phenylglycine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe D(-)-Alpha-Phenylglycine Sales Value (2021-2032)
  15. 6.7.2 Europe D(-)-Alpha-Phenylglycine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific D(-)-Alpha-Phenylglycine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific D(-)-Alpha-Phenylglycine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America D(-)-Alpha-Phenylglycine Sales Value (2021-2032)
  21. 6.9.2 South America D(-)-Alpha-Phenylglycine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa D(-)-Alpha-Phenylglycine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa D(-)-Alpha-Phenylglycine Sales Value Share by Country, 2025 VS 2032
7 D(-)-Alpha-Phenylglycine Country-level Sales and Value Analysis
  1. 7.1 Global D(-)-Alpha-Phenylglycine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global D(-)-Alpha-Phenylglycine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global D(-)-Alpha-Phenylglycine Sales by Country (2021-2032)
  4. 7.3.1 Global D(-)-Alpha-Phenylglycine Sales by Country (2021-2026)
  5. 7.3.2 Global D(-)-Alpha-Phenylglycine Sales by Country (2027-2032)
  6. 7.4 Global D(-)-Alpha-Phenylglycine Sales Value by Country (2021-2032)
  7. 7.4.1 Global D(-)-Alpha-Phenylglycine Sales Value by Country (2021-2026)
  8. 7.4.2 Global D(-)-Alpha-Phenylglycine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt D(-)-Alpha-Phenylglycine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt D(-)-Alpha-Phenylglycine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt D(-)-Alpha-Phenylglycine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Yuntao Biotechnology
  2. 8.1.1 Zhejiang Yuntao Biotechnology Company Information
  3. 8.1.2 Zhejiang Yuntao Biotechnology Business Overview
  4. 8.1.3 Zhejiang Yuntao Biotechnology D(-)-Alpha-Phenylglycine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Yuntao Biotechnology D(-)-Alpha-Phenylglycine Product Portfolio
  6. 8.1.5 Zhejiang Yuntao Biotechnology Recent Developments
  7. 8.2 JIN Yimeng Group
  8. 8.2.1 JIN Yimeng Group Company Information
  9. 8.2.2 JIN Yimeng Group Business Overview
  10. 8.2.3 JIN Yimeng Group D(-)-Alpha-Phenylglycine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 JIN Yimeng Group D(-)-Alpha-Phenylglycine Product Portfolio
  12. 8.2.5 JIN Yimeng Group Recent Developments
  13. 8.3 Hebei Zeshuo Pharmaceutical Technology
  14. 8.3.1 Hebei Zeshuo Pharmaceutical Technology Company Information
  15. 8.3.2 Hebei Zeshuo Pharmaceutical Technology Business Overview
  16. 8.3.3 Hebei Zeshuo Pharmaceutical Technology D(-)-Alpha-Phenylglycine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hebei Zeshuo Pharmaceutical Technology D(-)-Alpha-Phenylglycine Product Portfolio
  18. 8.3.5 Hebei Zeshuo Pharmaceutical Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 D(-)-Alpha-Phenylglycine Value Chain Analysis
  2. 9.1.1 D(-)-Alpha-Phenylglycine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 D(-)-Alpha-Phenylglycine Sales Mode & Process
  6. 9.2 D(-)-Alpha-Phenylglycine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 D(-)-Alpha-Phenylglycine Distributors
  9. 9.2.3 D(-)-Alpha-Phenylglycine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst